The agency will also soon issue final guidance for manufacturers on the development of generic versions of abuse-deterrent opioid formulations.
You Might Also Like
Also By This Author
Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.
- Gottlieb S. FDA takes important steps to stem the tide of opioid misuse and abuse. FDA Voice. 2017 Sep 28.